If you're seeing this message, that means
JavaScript has been disabled on your browser
, please
enable JS
to make this app work.
No tags found
Companies
No companies found
Advanced Search
Newsfeed
Alerts
Saved Lists
Sign Up for Free
Login
Update this Profile
Get Updates
11
Followers on Owler
MAKScientific
is developing drugs to treat disease by targeting the endocannabinoid system...
Read more
Overview
Competitors
News & Insights
MAKScientific
is developing drugs to treat disease by targeting the endocannabinoid system...
Read more
Founder
Alexandros Makriyannis
CEO Approval Rating
88/100
Weigh In
2004
Burlington
Massachusetts
Greater Boston
Private
Pharmaceuticals & Biotechnology
Pharmaceuticals
Biotechnology
2834
2836
NAICS listing
http://www.makscientific.com
Est. Annual Revenue
$5.0-25M
Agree?
Yes
No
Est. Employees
25-100
Agree?
Yes
No
News
Latest News
Feb 27, 2020
BioSpace
Makscientific: Tetra Bio-Pharma Enters into Co-Development Agreement with MAKScientificCo-Development will provide pipeline for next generation pharmacology research of Rx drugs to further secure growth for Tetra Bio-Pharma Inc
Jun 16, 2016
Business Wire
Press Release: Makscientific : Global Fatty Acid Amide Hydrolase (FAAH or Anandamide Amidohydrolase or EC 3.5.1.99) Pipeline Review of 7 Therapeutic Companies & Drug Profiles Activity 2016 - Research and Markets
Follow and Get Alerts
MAKScientific Competitors
1
Follow
2
Follow
3
Follow
4
Follow
5
Follow
6
Follow
7
Follow
8
Follow
9
Follow
10
Follow
Unlock 10 + competitors
Trending Companies